Minor cannabinoid research has been accelerated in recent years thanks to the federal legalization of hemp and state legalization of marijuana. This research has led to the rise in the popularity of cannabinoids such as CBN, CBG, and Delta THC variants. However, there is a multitude of other cannabinoids that can be found within the cannabis plant, including CBDM.
Cannabidiol monomethyl ether, or CBDM for short. According to a 2020 paper published in Scientific Reports, "we report a new series of phytocannabinoids that fills the gap between the pentyl and heptyl homologs of CBD and Δ9-THC, bearing a n-hexyl side chain on the resorcinyl moiety. At the best of our knowledge and according to the literature, no case of hexyl derivatives of cannabinoid has been reported so far. Conversely, cannabinoids with the same molecular formula and molecular weight have been classified as monomethyl ether derivatives of canonical phytocannabinoids."
CBDM was documented back in 1972, however, since it is found in such small quantities, it has been difficult to document its properties. In fact, CBDM exists in such small quantities, we are still unsure of its properties, even more than 50 years later. However, because it is related to CBD, researchers theorize it shares many properties similar to the more present cannabinoid.
Make no mistake, we are still learning new things about the cannabis plant every day. With time, we will continue to uncover just how cannabinoids like CBDM can help benefit humanity.